OUHSC Research News – Monday, March 6, 2023
Published: Friday, March 3, 2023
OUHSC Research News – Monday, March 6, 2023
Notices and Reminders
RESEARCH FORUM: Cutting edge capabilities at the OMRF Clinical Genomics Center
Speaker: Graham Wiley, Ph.D., Director, Clinical Genomics Center
Hosted by: Lijun Xia, M.D., Ph.D., OMRF Cardiovascular, Biology Research Program
Date: Thursday, March 9; 11 A.M. - 12 P.M.
Location: In-person (Wileman Learning Center) and Zoom Webinar – Please see the attached flyers for more information or visit https://omrf.org/research-forum/
Proposal Submission Timeline Calculating Tool
The Office of Research Administration (ORA) is pleased to announce the addition of a new proposal submission timeline calculating tool to the Research Administration website, which principal investigators and grant administrators can use to ensure they are meeting required internal review deadlines for submitting proposals to our office.
To use this calculator, please select your proposal type (Single Project Proposal vs. Multi-Project Proposal) and enter the sponsor's submission deadline in the box to calculate the date your proposal will be due to ORA (finalized proposal documents including all required signatures). The tool also calculates the due date to ORA for an optional proposal budget review.
Please follow the link below to access the calculating tool.
https://research.ouhsc.edu/research-administration/grants/internal-deadlines
OUHSC Research News is intended to notify faculty and staff of new funding opportunities, upcoming workshops and seminars, agency updates, and OUHSC policies and procedures that impact sponsored research. If your department or unit has an open funding opportunity or is offering a workshop event that you would like to be included in the newsletter, you can send it to the Office of Research Administration (ORA) at oradmin@ouhsc.edu. Items for the newsletter should be received no later than 5:00 PM on Thursday to be included in the following week’s issue.
Workshops and Seminars
2023 Oklahoma Geroscience Symposium (Save the date)
Date: Monday, April 3, 2023
Time: 8:25 - 5:00 PM CST with Faculty/Trainee Mixer to Follow at 5:00 PM. Poster session 12:15 - 2:00 together with lunch.
Location: In-person
Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104
Description: "Cell non-autonomous mechanisms of aging: Crosstalk between the periphery and the brain"
Sponsored by the Oklahoma Nathan Shock Center on Aging
Registration is free
Questions? If you have any questions regarding the symposium, please email Laura Otalora, Laura-Otalora@OUHSC.edu
Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/
Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/
2023 Oklahoma Gero-Oncology Symposium
Date: Tuesday, April 4, 2023
Time: 8:15 - 5:25 PM CST | Reception to Follow
Location: In-person & via Zoom
Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104
Description: Learn about the developments and progress happening in geriatric oncology regarding sarcopenia in aging and cancer cachexia from leading experts across the country. This symposium will feature a roundtable discussion with speakers from NCI and NIA as well as a poster session.
Full agenda coming soon.
Sponsored by OU Health Stephenson Cancer Center and the Oklahoma Nathan Shock Center on Aging
Questions? If you have any questions regarding the symposium, please email Emily Hulseberg at emily-hulseberg@ouhsc.edu.
Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/
Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/
2023 Annual Cancer Research Symposium
Registration Open Now!
The Annual Cancer Research Symposium is a one-day event with research focused in cancer biology, cancer prevention and control, and cancer therapeutics. The target audience is faculty, staff, postdoctoral and graduate students, and other cancer research focused colleagues.
WHEN Friday, March 10, 9:30 am - 5:10 pm (Reception to follow)
WHERE Nicholson Tower - 1000 NE 13th St. OKC, OK 73104
REGISTER Register HERE.
Questions? If you have any questions regarding the symposium, please contact Emily Hulseberg at Emily-Hulseberg@ouhsc.edu.
OCRID 10th Annual Research Symposium
Date: Tuesday, April 11, 2023, 8:00 AM – 6:00 PM CDT
Location: McKnight Center for the Performing Arts, 705 West University Avenue Stillwater, OK 74074
Description: The Oklahoma Center for Respiratory and Infectious Diseases is a multi-institutional center with investigators coming from Oklahoma State University, University of Oklahoma, and the Oklahoma Medical Research Foundation.
The OCRID Annual Research Symposium provides an opportunity for researchers and students in the fields of respiratory and infectious diseases to gather, network, and learn together from a group of outstanding local and national leaders in their fields. Research disciplines include molecular biology, pathology, animal models, disease pathogenesis, therapeutics, molecular mechanisms, and bioengineering.
The one-day symposium features keynote speakers, showcases the progress of OCRID investigators’ projects and the update from OCRID core facilities, and hosts a poster competition with cash prizes. A catered breakfast, refreshment breaks, and lunch will be provided throughout the day.
Registration and additional information: Please refer to the attached flyers.
OUHSC Funding Opportunities
The Center of Biomedical Research Excellence (COBRE) Pilot Project RFA
Description: The NIH/NIGMS-funded Oklahoma Center of Biomedical Research Excellence (COBRE) in Microbial Pathogenesis and Immunity invites proposals for pilot project awards. Pilot projects will enable investigators to generate data to support new lines of investigation funded by national level awards. The pilot project may constitute the entire basis for a new national level (NIH or NSF) funding proposal, or may extend the scope or strengthen a planned application. Pilot projects must be of high significance and enhance or generate funding proposals that will exert a high impact on the applicant’s field of research.
Eligibility Requirements: The project Principal Investigator (PI) must be a consecutive term, tenure-track, or tenured faculty member at an Institution in the State of Oklahoma. First preference will be given to junior investigators within 5 years of their initial appointment and who currently hold NIH New Investigator status. Established investigators (NIH Established Investigator, Associate Professor, and Professor) and those beyond the initial 5 year period are eligible, but the applicant must clearly demonstrate how the pilot project will add a new element or direction to the PI’s research program. The PI may not concurrently hold other COBRE or INBRE support as a full project or pilot project PI. This includes other COBRE programs in Oklahoma. Past recipients of pilot project awards will be considered for a second award contingent on priority and having fulfilled all requirements of the previous award.
Awards: The award will be $50,000 per annum in direct costs. Institutional F&A costs will also be provided for applicants at institutions outside of OUHSC. Projects may be funded for up to 2 years contingent upon fulfilling award requirements and satisfactory progress. Sub-contracts are not allowable.
Application Deadline: 5pm, March 31, 2023
Application format and additional information: Please see the attached flyer.
Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications
- Cycle I PHF Bridge Grant Program Deadline: April 3, 2023
The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques.
IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.
American Cancer Society Institutional Research Grant (ACS IRG) – 2023 Spring Cycle
Description: The ACS-IRG is a unique source of funding entrusted to Stephenson Cancer Center (SCC) that provides seed money for early-stage faculty interested in cancer-related research - the ACS has provided SCC with supplemental monies that allow support up to two awards. ACS-IRG funds will provide $50,000 to new/early stage faculty with Cancer Research pilot projects.
Eligibility Criteria:
- ASSISTANT PROFESSOR or equivalent level position that holds a Tenure- or Research-track appointment on OUHSC, OU-Norman or OU-Tulsa campus and within SIX years of first independent academic appointment.
- Without CURRENT grant support from national funding agencies (e.g. NIH, DOD, NSF, ACS).
Deadline: Wednesday, April 5th, 2023, Due by 5:00 PM (CST)
Application, Guidelines and more information can be found: Application, Forms & Guidelines | SCC Website
Questions: please contact the SCC Office of Cancer Research at CancerResearch@ouhsc.edu
OUHSC College of Medicine Research Fund
Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund. COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice. Applications will be reviewed by a scientific panel whose composition will be determined on the types of applications received. Awards generally fall within the $20,000 to $45,000 range ($45,000 maximum request).
All applications must be routed through the Office of Research Administration and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.
Below are New Guidelines for routing applications and for formatting applications for the COLLEGE OF MEDICINE ALUMNI ASSOCIATION (COMAA) research program:
- Submission of application for review
- At least five days prior to submission of the grant application, you must submit an electronic routing form using SOONERTRACKGRANTS (http://soonertrack.ouhsc.edu/SoonerTrackGrants.aspx).
- This program follows a Just-In-Time application process; therefore, approval of Institutional Review Board, Institutional Animal Care and Use Committee, Radiation Safety Committee and Institutional Biosafety Committee, where applicable, are not needed unless the application is being recommended for COMAA funding. Applicants should only submit this information when it is requested by the Office of the Vice President for Research. All protocols must be approved by the relevant review committees before funds are awarded.
- The completed COMAA application must be submitted via e-mail to COMAA-Research@ouhsc.edu (cc marybeth-humphrey@ouhsc.edu) no later than 5 pm, Wednesday, April 5, 2023. The application must be a single file in a pdf format and be titled “COMAA [PI Name]”. Only applications that conform to the COMAA Grant Guidelines will be forwarded to the Grant Review Panel for consideration.
- Questions about the application submission process should be addressed to Associate Dean for Research for the College of Medicine, Dr. Mary Beth Humphrey (Marybeth-humphrey@ouhsc.edu).
Please submit an electronic copy of the application along with a copy of the Completed and Approved Soonertrack Routing Form (Soonertrackgrants.ouhsc.edu). A screenshot of the completed online PDF form will be accepted). Application must be reviewed and approved for submission by the Office of Research Administration (ORA) prior to the final application being submitted.
The start date for funded COMAA proposals will be July 1, 2023.
Applications Due: Applications should be sent electronically to COMAA-Research@ouhsc.edu by 5 pm on Wednesday, April 5, 2023.
Guidelines for the Submission of Proposals: Please refer to the attached application guide.
Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs
Grant Type
|
Deadline
|
New Investigator Seed (requires nomination by college)
|
March 10, 2023
|
Clinician Scientist Development
|
March 10, 2023
|
Team Science
|
March 24, 2023
|
Presbyterian Health Foundation (PHF) New Investigator Seed Grant Program – Request For Applications
- Cycle I PHF New Investigator Seed Grant Program Deadline: March 10, 2023
The primary objective of the PHF New Investigator Seed Grant Program is to provide a two-year grant for OUHSC New Investigators to initiate research programs and obtain extramural funding. A secondary objective is to fund highly promising New Investigators from each of the six OUHSC professional colleges. Applicants must fit the following definition of a New Investigator: An investigator who has not previously received substantial, independent funding from NIH (e.g. R01-type funding) or a comparable funding agency. Multi-PI applications are not allowed. Each of the six OUHSC professional colleges (Allied Health, Dentistry, Medicine, Nursing, Pharmacy, and Public Health) may nominate one faculty member for this award. Applicants must be nominated by their professional college in order to apply for this award. The professional college nominating the faculty member must agree to assign a mentor for this project and must commit to providing the mentor with $2,500/year for mentoring activities; the mentor does not need to be an OUHSC faculty member. Each college may set up their own nomination process for this award.
The Principal Investigator must be an OUHSC primary faculty member. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu
PHF New Investigator Seed Grant recipients may not hold a PHF Bridge Grant, a PHF Clinician Scientist Development Grant, a PHF Team Science Grant, a Research Support Grant, or a PHF Seed Grant for the duration of this award.
Presbyterian Health Foundation (PHF) Clinician Scientist Development Grant Program – Request For Applications
- Cycle I PHF Clinician Scientist Development Grant Program Deadline: March 10, 2023
The primary objective of the PHF Clinician Scientist Development Grant Program is to provide funding to a new or early stage clinician scientist faculty member. This award is designed to support the applicant’s clinical and/or translational research project and to assist him or her with advancing this research project to a level that will be competitive for funding through a federal career development award mechanism. This program can provide funding for up to two years. The second year of funding, will be based on successful achievement of identified milestones, completion of an application for Year Two funds, and whether funds are available.
The Principal Investigator must be an OUHSC primary faculty member with appointment at OUHSC as an Assistant Professor. New or early stage clinical scientist faculty members with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC. Requests should be sent to ORA4PHF@ouhsc.edu). Applicants must not have had a prior NIH career development award or an independent NIH R01 award; must have an independent clinical and/or translational research project; must have an identified senior, experienced research mentor; and may not have another PHF grant during the duration of this award.
Presbyterian Health Foundation (PHF) Team Science Grant Program – Request For Applications
- Cycle I PHF Team Science Grant Program Deadline: March 24, 2023
The primary objective of this PHF Team Science Grant is to foster innovative, collaborative approaches to research projects involving multiple investigators. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two investigators and their respective expertise and/or disciplines. The proposal must consist of two or more investigators, with the majority at OUHSC, who can develop a broadly based, multidisciplinary research program focused on a specific disease entity, biomedical problem area, or clinically relevant problem. The combination and integration of studies may include basic, clinical, community-based and/or translational research endeavors. The proposal should focus on developing collaborative relationships and co-authored papers required for submission of multi-PI grants, program project grants, center grants, or other large collaborative-type grants (PCORI or AHRQ). The funding for this program can be for up to three years with the 2nd and 3rd year of funding, if funds are available, based on successful achievement of identified milestones, quality of specified milestones to be met during the next year of funding, and submission of a team-type grant application by the end of the 2nd year.
Each proposal submitted must consist of two or more investigators with a single investigator identified as the Contact PI/Team Leader. The Contact PI/Team Leader must be an OUHSC primary faculty member; adjunct faculty members are not eligible. At least half of the investigators on the team must be OUHSC primary faculty members. The other investigators may be from other institutions.
Guidelines and Application Forms are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.
Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- Ipsen, a global biopharmaceutical company, is seeking novel and innovative leads to treat rare diseases and rare neuroscience disease indications. A range of therapeutic areas, targets, and mechanisms-of-action and classes of molecules are of interest, with a specific focus on small molecule, peptide, biologics, nucleic acids, RNA therapies and antibody conjugates. Out of scope are gene therapy, cell therapy, vaccines, generics and natural products. Submission entails a 1-pg non-confidential proposal form, including workplan and budgetary requirements. (deadline 4/12).
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit Description: Grant proposals are being accepted for the 2023 Spring cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Grant template and Submission Checklist provided with this notice. Investigators should request the budget template from the Protocol Support Unit.
Deadline: April 3, 2023 at 5 pm CST
Link to the full announcement or a flier: Please refer to the attached flyer for additional funding criteria and details
NIH Notices
- NIH Redesign of the xTrain Module in eRA Commons
(NOT-OD-23-094)
- Expiration of the COVID-19 Public Health Emergency
(NOT-OD-23-095)
- NIH Can No Longer Grant Common Rule Exceptions to the Use of a Single IRB for Multi-site Research After the COVID-19 Public Health Emergency Expiration Date of May 11, 2023
(NOT-OD-23-097)
- Notice of Pre-Application Webinar for RFA-AG-24-011 - Research Coordinating Center on the Exposome and AD/ADRD: Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed)
(NOT-AG-23-010)
- Notice of Pre-Application Webinar for Funding Opportunities on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation
(NOT-AG-23-011)
- Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-24-022)
(NOT-EB-23-003)
- Notice to Extend the Expiration Date for All NIH Career Development Award (K) Parent Announcements
(NOT-OD-23-096)
- The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2023 SGM Research Investigator Awards Program
(NOT-OD-23-100)
- Notice of Pre-Application Webinar for PAR-23-035: Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
(NOT-RM-23-007)
- Request for Information (RFI): Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials
(NOT-TR-23-006)
- Notice of Change to the Application Due Date and Correction of Budget Submission Requirement for RFA-CA-23-002 "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
(NOT-CA-23-047)
- Notice of Changes to Application Submission Instructions for RFA-DA-22-040, "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)"
(NOT-DA-23-020)
- Notice to Extend the Expiration Date of PAR-20-213 "National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed)"
(NOT-GM-23-036)
- Notice of Intent to Publish a Funding Opportunity Announcement for Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
(NOT-AI-23-033)
- Notice of Intent to Reissue PA-20-208, Substance Use/Substance Use Disorder Dissertation Research Award
(NOT-DA-23-018)
- Notice of Intent to Publish a Funding Opportunity Announcement for Established Data Repositories and Knowledgebases (Clinical Trials Not Allowed)
(NOT-OD-23-099)
- Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions to Add or Expand Research and Administrative Supplements on Cutting Edge Pain Research in Rheumatic, Skin, and Musculoskeletal Disease.
(NOT-AR-23-015)
- Notice of Special Interest (NOSI): Administrative Supplements to NIAMS-funded T32 Training Grants to Better Incorporate Pain Related Research in Rheumatic, Skin and Musculoskeletal Diseases Workforce Development
(NOT-AR-23-016)
- Notice of Special Interest (NOSI): Administrative supplements to examine the effects of digital tools and interventions on patient-provider communication across the cancer control continuum
(NOT-CA-23-041)
- Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs
(NOT-CA-23-045)
- Notice of Special Interest (NOSI): Administrative Supplements to Leverage Network Infrastructure to Advance Multisite Research for Women, Children, Pregnant and Lactating Individuals and/or Persons with Disabilities
(NOT-HD-23-005)
- Notice of Special Interest (NOSI): Administrative Supplements to NINR Institutional Research Training Grants (T32) to Increase Capacity for Research to Prevent Firearm Injury and Related Health Disparities
(NOT-NR-23-009)
NIH Funding Opportunities
- Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional)
(PAR-23-121)
Application Receipt Date(s): February 07, 2024
- Genomic Community Resources (U24 Clinical Trial Not Allowed)
(PAR-23-124)
Application Receipt Date(s): January 25, 2026
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
(PAR-23-130)
Application Receipt Date(s): May 07, 2026
- Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
(PAR-23-131)
Application Receipt Date(s): May 07, 2026
- NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
(PAR-23-263)
Application Receipt Date(s): Multiple dates, see announcement.
- NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
(PAR-23-265)
Application Receipt Date(s): Multiple dates, see announcement.
- NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed)
(PAR-23-266)
Application Receipt Date(s): Multiple dates, see announcement.
- Roybal Centers for Translational Research on Aging (P30 Clinical Trial Required)
(RFA-AG-24-006)
Application Receipt Date(s): June 23, 2023
- Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)
(RFA-AG-24-007)
Application Receipt Date(s): Multiple dates, see announcement.
- Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed)
(RFA-AG-24-008)
Application Receipt Date(s): Multiple dates, see announcement.
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
(RFA-AG-24-014)
Application Receipt Date(s): October 18, 2024
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
(RFA-AG-24-015)
Application Receipt Date(s): October 18, 2024
- Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional)
(RFA-AT-24-001)
Application Receipt Date(s): October 01, 2023
- Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)
(RFA-DA-24-001)
Application Receipt Date(s): August 13, 2025
- Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)
(RFA-DK-22-037)
Application Receipt Date(s): October 25, 2023
- Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)
(RFA-ES-23-007)
Application Receipt Date(s): November 07, 2023
- Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed)
(RFA-MH-23-275)
Application Receipt Date(s): October 10, 2023
- Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional)
(RFA-NR-23-002)
Application Receipt Date(s): May 01, 2023
- Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
(RFA-NR-23-003)
Application Receipt Date(s): May 01, 2023
- Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required)
(RFA-NR-23-004)
Application Receipt Date(s): May 01, 2023
Other Funding Opportunities
Cystic Fibrosis Foundation Clinical Research Scholars Program (CRSP) Award
Description: The CRSP Award is designed to enable promising early-career physician scientists to enhance their clinical research proficiency and support their development of the necessary clinical research capabilities to become independent investigators who formulate and lead multi-center, clinical research studies. Investigators looking to grow clinical research projects and receive mentorship as they develop multi-center, prospective research proposal submissions are strongly encouraged to apply. For questions, please contact Elizabeth Yu (eyu@cff.org).
LOI deadline: LOI applications must be submitted online at awards.cff.org by March 9, 2023. Afterward, a selected number of LOIs will be invited to submit a complete application to awards.cff.org. Applicants will be notified in early 2023.
Link to Full Announcement: https://www.cff.org/researchers/clinical-research-scholars-program-award
DoD Ovarian Cancer Research Program (OCRP)
- Investigator-Initiated Research Award (IIRA)
- Ovarian Cancer Academy Award - Early-Career Investigator (OCA)
- Pilot Award (PA)
Pre-Application: April 17, 2023
Application: July 21, 2023
Link to Full Announcement: https://cdmrp.health.mil/funding/ocrp
The Leona M. and Harry B. Helmsley Charitable Trust - ADVANCING THE UNDERSTANDING OF TYPE 1 DIABETES PATHOGENESIS (BIOSAMPLES PROVIDED FROM A PRIMARY PREVENTION TRIAL)
Description: This RFP seeks projects to improve the understanding of T1D pathogenesis using samples and data from a trial investigating oral insulin as a potential method to prevent initiation of T1D in children at high genetic risk.
Concept Notes due: March 17, 2023
Selected applicants invited to submit Full Grant Proposals: April 18, 2023
Full Grant Proposals due: July 03, 2023
Link to Full Announcement: https://www.gppad.org/de-en/rfp/
The Leona M. and Harry B. Helmsley Charitable Trust- Request for Applications to advance collaborative research in T1D prevention
Description: This RFP supported in collaboration with JDRF Australia, seeks collaborative projects to help answer unknowns about T1D biological mechanisms, with studies on its samples and data collected from pregnancy through childhood from children with an immediate family member with T1D.
LOI Deadline: April 7, 2023
Link to Full Announcement: https://jdrf.org.au/for-researchers/type-1-diabetes-prevention-rfa/
HRSA Advanced Nursing Education Workforce (ANEW) Program (HRSA-23-014)
Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO). The Advanced Nursing Education Workforce (ANEW) Program aims to increase the number of primary care nurse practitioners, clinical nurse specialists, and certified nurse midwives trained and prepared to provide primary care services, mental health and substance use disorder care, and maternal health care. The grants will support the training and graduation of advanced practice registered nursing (APRN) students and trainees in these disciplines.
Application Deadline: April 7, 2023
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-014?UTM_campaign=Funding+Announcement+-+Advanced+Nursing+Education+Workforce
HRSA Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program (HRSA-23-009)
Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO) for the Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program, which aims to prepare new Advanced Practice Registered Nurses (APRNs) to effectively provide primary care by supporting transition to practice through the expansion and/or enhancement of existing Nurse Practitioner (NP) residency programs. The program also focuses on the integration of behavioral health and maternal health into primary care by training new primary care providers, behavioral health providers, and certified nurse midwives in community-based settings.
HRSA will award approximately $30 million to up to 43 grantees over a period of four years.
Application Deadline: April 11, 2023
Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-009?UTM_campaign=NOFO+Announcement+-+ANE+NPRF+Program
Asahi Kasei Pharma to Sponsor Research for Drug Discovery Research and Technology: Open Innovation 2023
Description: Asahi Kasei Pharma is publicly calling for new proposals related to drug discovery research. (Following is the full press release; https://bwnews.pr/3g4PVmf)
The application period begins from January 5 and ends at 8:00 a.m. GMT on February 28, 2023. Proposals are solicited concerning new drug seeds (drug target and drug candidate) and technologies in the therapeutic fields of autoimmune disease, renal disease, neurodegenerative disease, bone disease and pain, and drug discovery platform technology.
Applications can be submitted through the website below: https://www.asahikasei-pharma.co.jp/a-compass/en/
Further information is available on link below: https://www.asahikasei-pharma.co.jp/a-compass/en/dl/ASAHIKASEIPHARMA_OPENINNOVATION_en.pdf
DoD Amyotrophic Lateral Sclerosis Research Program (ALSRP)
Pre-Application: 4-13-2023
Application: 7-13-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495104
DoD Breast Cancer Research Program (BCRP)
Pre-Application (Letter of Intent): 3-28-2023
Application: 4-11-2023
Pre-Application (Letter of Intent): 3-29-2023
Application: 6-28-2023
Pre-Application (Letter of Intent): 3-29-2023
Application: 6-28-2023
Pre-Application (Letter of Intent): 3-28-2023
Application: 4-11-2023
Pre-Application (Letter of Intent): 3-28-2023
Application: 4-11-2023
Pre-Application (Letter of Intent): 3-29-2023
Application: 6-28-2023
Pre-Application (Letter of Intent): 3-29-2023
Application: 6-28-2023
Pre-Application (Letter of Intent): 3-28-2023
Application: 4-11-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495102
DoD Epilepsy Research Program (ERP)
Pre-Application (Letter of Intent): 5-19-2023
Application: 6-23-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495101
DoD Peer Reviewed Medical Research Program (PRMRP)
Pre-Application (Letter of Intent): 4-12-2023
Application: 7-19-2023
Pre-Application (Letter of Intent): 3-29-202
Application: 4-26-2023
Pre-Application (Letter of Intent): 4-12-2023
Application: 7-19-2023
Pre-Application (Letter of Intent): 4-19-2023
Application: 5-31-2023
Pre-Application (Letter of Intent): 4-19-2023
Application: 5-31-2023
Pre-Application (Letter of Intent): 4-19-2023
Application: 5-31-2023
Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495103
Robert Wood Johnson Foundation (RWJF) Harold Amos Medical Faculty Development Program (AMFDP)
Description: The Harold Amos Medical Faculty Development Program (AMFDP) offers four-year postdoctoral research awards to physicians, dentists, and nurses from historically marginalized backgrounds. We expect scholars to spend at least 70 percent of their time engaged in research. Scholars should be committed to working toward eliminating health disparities especially within underserved populations; to support succeeding AMFDP scholars; and to achieving senior rank in academic medicine, dentistry, or nursing.
In this grant cycle, RWJF will fund up to 10 four-year awards of up to $420,000 each. Scholars will receive an annual stipend of up to $75,000 each, complemented by a $30,000 annual grant to support research activities.
Application Deadline: March 15, 2023
Link to Full Announcement: https://www.rwjf.org/en/grants/active-funding-opportunities/2023/harold-amos-medical-faculty-development-program.html?rid=0032S00002ZyzqpQAB&et_cid=2195901
The International Center for Responsible Gaming - REQUEST FOR APPLICATIONS ON RESEARCH ON PRE-COMMITMENT AS A PREVENTION MEASURE TO REDUCE GAMBLING-RELATED HARMS
Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to study the effectiveness of “pre-commitment,” a prevention strategy that encourages gamblers to set limits on money and time spent gambling. Applicants may request up to a total of $75,000 per year for up to two years plus 15 percent in Facilities & Administration costs. Total amount that may be requested is $172,500.
Application Deadline: May 15, 2023
Link to Full Announcement: https://www.icrg.org/information/apply-for-icrg-funding
Cystic Fibrosis Foundation Multiple Principal Investigator Clinical Award
Description: The Multiple Principal Investigator (MPI) Clinical Award provides support for multi-investigator-initiated clinical research projects that have the potential to make an important contribution to the CF Foundation’s mission. Research projects may be designed to address a range of research areas, from clinical pilot and feasibility work to clinical (observational/interventional), translational or epidemiologic study approaches. Each investigator is expected to be a significant contributor to the project and share the responsibility and authority for leading and directing the project. Collaborations that bring new investigators and technologies into the CF research community will be given highest priority. Please note that applicants must speak with program staff prior to submission of an LOI. For questions, please contact Dara Riva (driva@cff.org).
Letter of Intent Due: March 22, 2023
Link to Full Announcement: https://www.cff.org/researchers/multiple-principal-investigator-clinical-award
Cystic Fibrosis Foundation Health Equity Team Science Award
Description: The Health Equity Team Science Award RFA will help address key research questions related to health disparities and to improve health equity within the CF Community. The RFA aims to fund cross-disciplinary teams that may propose up to three related research projects (each led by a separate principal investigator) that share a well-defined theme and overall objective. We are holding a webinar on February 28, 2023 from 1-2pm ET to review RFA content and the submission process, and will allow time for Q&A. Please note that applicants must speak with program staff prior to submission of an application. For questions, please contact Dara Riva (driva@cff.org).
Letter of Intent Due: March 29, 2023
Link to Full Announcement: https://www.cff.org/researchers/health-equity-team-science-award
Documents to download
-
PHF Clinician Scientist Development Grant Guidelines-Year One - Deadline 3.10.23(.docx, 60.03 KB) - 0 download(s)
-
PHF Clinician Scientist Development Grant Guidelines-Year Two - Deadline 3.10.23(.docx, 59.63 KB) - 0 download(s)
-
PHF New Investigator Seed Grant Guidelines-Year One - Deadline 3.10.23(.docx, 65.18 KB) - 0 download(s)
-
PHF New Investigator Seed Grant Guidelines-Year Two - Deadline 3.10.23(.docx, 63.69 KB) - 0 download(s)
-
PHF Team Science Grant Guidelines-Year One - Deadline 3.24.23(.docx, 68.34 KB) - 0 download(s)
-
PHF Team Science Grant Guidelines-Year Two - Deadline 3.24.23(.docx, 61.7 KB) - 0 download(s)
-
PHF Team Science Grant Guidelines-Year Three - Deadline 3.24.23(.docx, 61.32 KB) - 0 download(s)
-
2023 HHDC Equipment Grant LOI(.docx, 44.14 KB) - 0 download(s)
-
2023 HHDC Novel Pilot Grant for Post Docs LOI(.docx, 44.48 KB) - 0 download(s)
-
2023 HHDC Novel Pilot Grant LOI(.docx, 48.7 KB) - 0 download(s)
-
2023 HHDC Team Science Grant LOI(.docx, 44.39 KB) - 0 download(s)
-
2023 HHDC Travel Stipend LOI(.docx, 31.38 KB) - 0 download(s)
-
2023 HHDC Bridge Grant LOI(.docx, 46.02 KB) - 0 download(s)
-
2023 HHDC-SCC Novel Pilot Grant LOI(.docx, 46.84 KB) - 0 download(s)
-
2023 HHDC-SCC Team Science Grant LOI(.docx, 45.02 KB) - 0 download(s)
-
FOA_COMAA_Ltr2023_Humphrey(.doc, 182 KB) - 0 download(s)
-
IITFC_FOA_Spring_2023(.pdf, 695.61 KB) - 0 download(s)
-
IITFC Submission Checklist_Spring 2023(.pdf, 205.33 KB) - 0 download(s)
-
IITFC Grant Application template_v1.0(.pdf, 152.2 KB) - 0 download(s)
-
2023 Oklahoma Gero-Oncology Symposium(.pdf, 329.66 KB) - 0 download(s)
-
10th Symposium CfR - Final(.pdf, 8.37 MB) - 0 download(s)
-
10th Symposium CfA - Final(.pdf, 6.36 MB) - 0 download(s)
-
PHF Bridge Grant Program Guidelines - Due Date 4.3.23(.docx, 63.68 KB) - 0 download(s)
-
Research Forum Flyer-Wiley local(.pdf, 1.32 MB) - 0 download(s)
-
Research Forum Flyer-Wiley Zoom(.pdf, 1.32 MB) - 0 download(s)
-
Flyer_ACS IRG_2023-Spring(.pdf, 127.84 KB) - 0 download(s)
-
Guidelines_ACS IRG_2023-Spring(.pdf, 335.56 KB) - 0 download(s)
-
COBRE Pilot RFA 030123(.pdf, 108.76 KB) - 0 download(s)